+16.6%
EMR vs NDAQ
+4.3%
+12.3%
-23.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NDAQ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | -1.9% | +3.6% | +2.1% |
| 7D | -1.5% | -2.4% | +0.9% | -1.1% |
| 30D | -5.6% | +2.5% | -8.1% | -6.1% |
| 3M | +7.9% | +9.9% | -2.0% | +6.4% |
| 6M | +6.0% | +9.4% | -3.4% | +4.2% |
| YTD | +16.4% | +0.4% | +16.0% | +16.6% |
| 1Y | +16.6% | +4.0% | +12.6% | +14.2% |
| All | +16.6% | +4.3% | +12.3% | +14.2% |
Cumulative growth
Daily Returns
Daily percentage return beside NDAQ.
Daily Out/Under-Performance
Portfolio return minus NDAQ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NDAQ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NDAQ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling